Jefferies Group started to build up the position in Prometheus Biosciences in Q1 2023. Since then they sold 12.6 Thousand shares. The investor sold all their shares in Q2 2023 and doesn't own any shares in Prometheus Biosciences anymore.
Avg closing price
Price range
Sold -12.6 Thousand shares
Q2 2023
Avg closing price
$181.30
Price range
$108.58
-
$199.92
New holding (+12.6 Thousand shares)
Q1 2023
Avg closing price
$115.10
Price range
$103.46
-
$126.29
News about Prometheus Biosciences Inc and Jefferies Group